Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwang-il Kim

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Annals of Geriatric Medicine and Research|June 11, 2025
Standardized Measurement of Physical Performance and Muscle Strength for Sarcopenia: Expert-based Delphi ConsensusSeung-Kyu Lim, Jaewon Beom, Sang Yoon Lee, et al.
Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.
Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.
Journal of Clinical Medicine|March 6, 2021
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort StudyIn-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, et al.
Journal of the American Heart Association|March 15, 2021
Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South KoreaJeong-Hun Shin, Mi-Hyang Jung, Chang Hee Kwon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 25, 2021
Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in koreaMi-Hyang Jung, Ju-Hee Lee, Chan Joo Lee, et al.
Korean Circulation Journal|April 7, 2022
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure TargetsDae-Hee Kim, In-Jeong Cho, Woohyeun Kim, et al.
Cardiovascular Diabetology|October 20, 2020
Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort studyHack-Lyoung Kim, Hyue Mee Kim, Chang Hee Kwon, et al.
Journal of the American Heart Association|March 19, 2021
Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South KoreaChang Hee Kwon, Woohyeun Kim, Jeong-Hun Shin, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Annals of Geriatric Medicine and Research|June 11, 2025
Standardized Measurement of Physical Performance and Muscle Strength for Sarcopenia: Expert-based Delphi ConsensusSeung-Kyu Lim, Jaewon Beom, Sang Yoon Lee, et al.
Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.
Trials|July 3, 2019
Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trialMin-Gu Kang, Kwang-Il Kim, Sang Hyun Ihm, et al.
Journal of Clinical Medicine|March 6, 2021
Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort StudyIn-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, et al.
Journal of the American Heart Association|March 15, 2021
Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South KoreaJeong-Hun Shin, Mi-Hyang Jung, Chang Hee Kwon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 25, 2021
Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in koreaMi-Hyang Jung, Ju-Hee Lee, Chan Joo Lee, et al.
Korean Circulation Journal|April 7, 2022
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure TargetsDae-Hee Kim, In-Jeong Cho, Woohyeun Kim, et al.
Cardiovascular Diabetology|October 20, 2020
Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort studyHack-Lyoung Kim, Hyue Mee Kim, Chang Hee Kwon, et al.
Journal of the American Heart Association|March 19, 2021
Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South KoreaChang Hee Kwon, Woohyeun Kim, Jeong-Hun Shin, et al.
Pageof 30